Shopping Cart
Remove All
Your shopping cart is currently empty
JS006 is a humanized IgG4κ monoclonal antibody inhibitor targeting TIGIT/CD155. It is applicable in the study of advanced and/or metastatic cancers, such as non-small cell lung cancer (NSCLC), advanced lymphoma, and advanced/metastatic triple-negative breast cancer (TNBC), particularly when resistance to PD-1/PD-L1 inhibitors has developed.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | JS006 is a humanized IgG4κ monoclonal antibody inhibitor targeting TIGIT/CD155. It is applicable in the study of advanced and/or metastatic cancers, such as non-small cell lung cancer (NSCLC), advanced lymphoma, and advanced/metastatic triple-negative breast cancer (TNBC), particularly when resistance to PD-1/PD-L1 inhibitors has developed. |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.